Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Alzheimer disease is a progressive neurodegenerative disorder characterized by specific brain pathologies.
• The apolipoprotein E (ApoE) gene, particularly the epsilon4 allele, is a known genetic risk factor for late-onset Alzheimer disease.
• The precise mechanism by which ApoE influences Alzheimer-like pathology onset remains an active area of research.

Purpose of the Study:

• To investigate the impact of the apolipoprotein E (ApoE) epsilon4 allele on the age of onset for Alzheimer-like brain lesions.
• To correlate the presence of ApoE polymorphisms with the degree of cerebral beta-amyloidosis and neurofibrillary tangle formation in non-demented individuals.

Main Methods:

• Analysis of brain tissue from 147 routine autopsy cases of individuals aged 50-93 years without clinical dementia.
• Genotyping for common apolipoprotein E (ApoE) polymorphisms (epsilon2, epsilon3, epsilon4).
• Histopathological assessment of beta-amyloid plaques, diffuse amyloid deposits, cerebrovascular amyloid, and neurofibrillary tangles in the hippocampus and adjacent cortical areas.

Main Results:

• Individuals carrying the ApoE epsilon4 allele exhibited significantly higher prevalence of senile plaques, diffuse amyloid deposits, cerebrovascular amyloid, and neurofibrillary tangles compared to non-carriers.
• In the ApoE epsilon3/4 subgroup, increased beta-amyloid was evident by the mid-60s, with neurofibrillary tangles appearing slightly earlier.
• The ApoE epsilon2 allele appeared to be associated with a delay in the onset of these neuropathological lesions.

Conclusions:

• The apolipoprotein E (ApoE) epsilon4 allele promotes the earlier development of beta-amyloid and neurofibrillary tangles in the aging brain.
• The increased frequency of these Alzheimer-like lesions in ApoE epsilon4 carriers likely contributes to their elevated risk of developing Alzheimer disease.
• These findings underscore the significant role of ApoE genetics in the early neuropathological changes associated with Alzheimer disease risk.